a leading designer, manufacturer and global
distributor of minimally invasive medical device technology for diagnostic
and therapeutic procedures. Since its founding in 1963, Cook has created
innovative technologies for drug-eluting and bare metal stents, aortic and
vascular endografts, catheters, wire guides, introducer needles and
sheaths, embolization coils, medical biomaterials and contract
manufacturing of biopharmaceuticals, vena cava filters and other minimally
invasive medical devices for radiology, cardiology, urology and women's
health, critical care medicine, surgery, gastroenterology, bone access and
endovascular therapies.
About Cardica
Cardica is a leading provider of automated anastomosis systems for
coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures
with easy-to-use automated systems, Cardica's products provide
cardiovascular surgeons with rapid, reliable and consistently reproducible
anastomoses, or connections of blood vessels, often considered the most
critical aspect of the CABG procedure. Cardica's C-Port(R) Distal
Anastomosis Systems are marketed in Europe and the United States. The
PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan,
and Cardica has received 510(k) clearance to market the PAS-Port system in
the United States. Cardica also is developing additional devices with Cook
Medical to facilitate vascular closure and other surgical procedures.
Forward-Looking Statements
This press release contains "forward-looking" statements, including
statements relating to the potential benefits of the PFO closure device.
Any statements contained in this press release that are not historical
facts may be deemed to be forward-looking statements. The words "believe,"
"may," "potentially" or similar expressions are intended to identify
forward-looking statements. There are a number of important factors that
could cause Cardica's results to differ materially from those indicated by
t
'/>"/>
SOURCE Cardica, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries2.
Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery3.
Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family4.
Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair5.
Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress6.
Cardica to Present at Jefferies 2nd Annual Healthcare Conference7.
Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis8.
Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market9.
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy10.
Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children11.
IsoTis Receives FDA Clearance for Accell Family of Products